Company News

ICIG announces the appointment of Dr Michael Quirmbach as CEO and President, CordenPharma Michael Quirmbach will succeed Dr Riku Rautsola as CEO and President, who will transition to the role of a Senior Adviser to the Executive Leadership Team to support a smooth... Ashfield appoints President of Global Business Development Mr Esgro assumes his position at Ashfield having most recently served as Vice President of Strategic Business Development US Commercial for Iqvia where he was responsible for... Arcis Biotechnology appoints Non-Executive Chairman Catalent appoints Ricardo Pravda to lead human resources function Pravda succeeds Lance Miyamoto who retired on 30 June, and is currently serving as an adviser to the company Romil creates new UK National Sales Manager position Paul Stubbings will start in the position to allow Sales Director Anthony Lenk to dedicate more time to the company’s rapidly growing direct sales and distributor-based... Nanoform appoints new head of investor relations Henri von Haartman will be the company’s new Director of Investor Relations Verona Pharma makes two senior appointments Nina Church joins as Executive Director of Global Clinical Development and Nancy Herje as Senior Director of Clinical Operations Mereo BioPharma appoints Head of Pharmaceutical Development Cambrex makes three senior appointments Bruno Biscaro has been appointed President of Drug Products, Joe Nettleton as President of Drug Substance, and Simon Edwards as President of CDMO Sales & Marketing The Marchesini Group appoints new Sales Director Francesco Stanzani will start his new role with immediate effect based in Pianoro Medherant appoints new CEO John Burt will replace Current CEO, Nigel Davis, who will stay on as Chief Business Officer Connect 2 Cleanrooms appoints new MD and CEO Michael Wright will succeed founding MD Joe Govier who has moved to the CEO role Ex-FDA Commissioner joins Pfizer Scott Gottlieb will also be a part of the Regulatory and Compliance Committee and the Science and Technology Committee of Pfizer’s Board Newcomer Quell Therapeutics appoints Iain McGill as CEO The company was founded in March 2019, in a partnership between prominent experts from King's College London, University College London, and Hannover Medical School Dr Bartu Ahiska is new Senior VP at Oxford BioDynamics In his new role Ahiska will spearhead the commercialisation of the group’s EpiSwitch technology platform Domain Therapeutics adds Sylvie Ryckebusch to Board Ryckebusch joins Domain from Merck Serono Symbiosis Pharmaceutical Services appoints Helen Caddy-Leach Caddy-Leach will take on the role of Business Development Manager to support growing US presence MG America appoints Janice Wortham as Regional Sales Manager Wortham will cover the Processing division covering some on the most important pharma stronghold in the US ReViral appoints Alex Sapir as new CEO Sapir will be based at North Carolina’s Research Triangle Park alongside the company’s new CMO, Seth Hetherington Uhlmann Packaging Systems has new US Regional Sales Manager Markus Leuprecht will take over leading the Southwestern US and Texas Lyndra Therapeutics has new CEO Dr Patricia Hurter will begin her new post on 3 September TraceLink appoints four new Board Members New appointments include prominent supply chain industry leaders and former industry analysts; Roddy Martin, John Bermudez, Kevin Young and Steve Collins Ulrich Platte is new CFO of eTheRNA immunotherapies Platte will start at the mRNA immunotherapy company on 3 June Idifarma announces new Director of Operations Daniel Rivero will join the Spanish CDMO from 3P Biopharmaceuticals

Trending Articles

  1. THX Pharma appoints Julien Veys as deputy chief executive officer Leadership appointment supports the company’s strategy to advance regulatory approval and commercialization of rare neurology therapies
  2. Kindeva announces leadership transition to support strategic growth David Stevens assumes CEO role as part of a planned succession strategy
  3. Astoriom appoints Will Edwards as Chief Executive Officer Strategic appointment to support global scale-up of sample management operations
  4. Rentschler Biopharma appoints Detra Glinatsis as head of U.S. business development Glinatsis returns to lead U.S. growth strategy and build on Milford site expansion
  5. Seasoned biotherapeutics leader Thomas J. Farrell joins NanoSyrinx as CEO Appointment supports NanoSyrinx’s transition from platform development to clinical-stage intracellular medicines

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all